Literature DB >> 30561154

Primary muscle involvement in a 15-year-old girl with the recurrent homozygous c.362dupC variant in FKBP14.

Marco Castori1, Chiara Fiorillo2, Emanuele Agolini3, Michele Sacco4, Carlo Minetti2, Antonio Novelli3, Giuseppe Guglielmi5,6, Enrico Bertini7.   

Abstract

Kyphoscoliotic Ehlers-Danlos syndrome associated with FKBP14 (FKBP14-kEDS) is an ultrarare autosomal recessive disorder reported in less than 30 individuals so far. In its original description, emphasis was put on the mild muscle involvement. Further reports confirm that FKBP14-kEDS is distinguishable from primary muscle disorders by the lack of progressive muscle disease. We report a 15-year-old girl with FKBP14-kEDS as a result of the recurrent c.362dupC variant, who also showed severe involvement of the lower limb muscles. She never attained autonomous walking and presented significant lower limb weakness. Lower limb magnetic resonance imaging showed a pattern of multiple muscle involvement. Further musculoskeletal assessment revealed significant bone mass density reduction of the spine, unilateral congenital hip dysplasia, and occipitoatlantoaxial instability. This patient points out the existence of a wider phenotypic spectrum of FKBP14-kEDS to include early onset muscle disease.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990FKBP14; Ehlers-Danlos syndrome; kyphoscoliotic; muscle dystrophy; musculocontractural

Mesh:

Substances:

Year:  2018        PMID: 30561154     DOI: 10.1002/ajmg.a.61006

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Genome analysis and knowledge-driven variant interpretation with TGex.

Authors:  Dvir Dahary; Yaron Golan; Yaron Mazor; Ofer Zelig; Ruth Barshir; Michal Twik; Tsippi Iny Stein; Guy Rosner; Revital Kariv; Fei Chen; Qiang Zhang; Yiping Shen; Marilyn Safran; Doron Lancet; Simon Fishilevich
Journal:  BMC Med Genomics       Date:  2019-12-30       Impact factor: 3.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.